Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for assessing the response to PD-1/PDL-1 targeting drugs

Method for assessing the response to PD-1/PDL-1 targeting drugs

US Patent 11293066 · Granted Apr 5, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for assessing the response to PD-1/PDL-1 targeting drugs2021
Use of inhibitors of scinderin and/or ephrin-A1 for treating tumors2011